has anyone else considered the impact of the recent impressive results in kidney disease progression.
the CREDENCE trial Released results at the major Australian Nephrology conference last week and announced some pretty amazing reductions in negative disease outcomes.
I'm not a pharmacist so would be interested to know if anyone with relevant knowledge could speak to whether this treatment works on similar pathways, or if DXB-200 could work in unison.
- Forums
- ASX - By Stock
- Competition in KD
has anyone else considered the impact of the recent impressive...
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
(20min delay)
|
|||||
Last
30.0¢ |
Change
-0.005(1.64%) |
Mkt cap ! $164.5M |
Open | High | Low | Value | Volume |
31.0¢ | 31.0¢ | 30.0¢ | $818.6K | 2.683M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 572150 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.5¢ | 10850 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 572150 | 0.300 |
7 | 252482 | 0.295 |
14 | 692285 | 0.290 |
8 | 239548 | 0.285 |
8 | 222379 | 0.280 |
Price($) | Vol. | No. |
---|---|---|
0.305 | 10850 | 1 |
0.310 | 248198 | 3 |
0.315 | 237371 | 4 |
0.320 | 529798 | 8 |
0.325 | 119810 | 5 |
Last trade - 16.10pm 29/03/2024 (20 minute delay) ? |
|
|||||
Last
30.0¢ |
  |
Change
-0.005 ( 1.64 %) |
|||
Open | High | Low | Volume | ||
31.0¢ | 31.0¢ | 30.0¢ | 640607 | ||
Last updated 15.54pm 29/03/2024 ? |
Featured News
DXB (ASX) Chart |